Litcius/Paper detail

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2

Matthias Tenbusch, Sofie Schumacher, Emanuel Vogel, Alina Priller, Jürgen Held, Philipp Steininger, Stephanie Beileke, Pascal Irrgang, Ronja Brockhoff, Jon Salmanton‐García, Kathrin Tinnefeld, Hrvoje Mijočević, Kilian Schober, Christian Bogdan, Sarah Yazici, Percy A. Knolle, Oliver A. Cornely, Klaus Überla, Ulrike Protzer, Hedwig Roggendorf, Otto Zelger, Catharina Christa, Samuel Jeske, Sarah Heringer, Rayya Alsalameh, Jan Esse, Jochen Mattner, Monika Wytopil

2021The Lancet Infectious Diseases133 citationsDOIOpen Access PDF

Topics & Concepts

HeterologousPrime (order theory)VaccinationVirologyCoronavirus disease 2019 (COVID-19)Computer scienceBiologyMedicineGeneticsMathematicsCombinatoricsPathologyDiseaseGeneInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisAnimal Virus Infections Studies
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 | Litcius